Evidence map›Paper›PMID 40593004›Full record

ArticleScientific reports2025

V

Matthew P Johnson, Mohammad T Al Bataineh, Sreejisha P Sreedharan, Herbert F Jelinek, Michael Pycraft Hughes

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew P JohnsonDepartment of Biomedical Engineering and Biotechnology, Khalifa University of Science and Technology, Shakhbout bin Sultan St., Abu Dhabi, UAE.ORCID http://orcid.org/0000-0002-8909-9996
Mohammad T Al BatainehDepartment of Basic Medical Sciences, College of Medicine, Yarmouk University, Irbid, Jordan. m.albataineh@yu.edu.jo.ORCID http://orcid.org/0000-0002-8855-5320
Sreejisha P SreedharanHealthcare Engineering Innovation Group, Khalifa University of Science and Technology, Shakhbout bin Sultan St., Abu Dhabi, UAE.
Herbert F JelinekDepartment of Medical Sciences, Khalifa University of Science and Technology, Shakhbout bin Sultan St., Abu Dhabi, UAE.ORCID http://orcid.org/0000-0002-1573-3659
Michael Pycraft HughesDepartment of Biomedical Engineering and Biotechnology, Khalifa University of Science and Technology, Shakhbout bin Sultan St., Abu Dhabi, UAE. michael.hughes@ku.ac.ae.ORCID http://orcid.org/0000-0001-7385-5876

Funding

Khalifa University of Science, Technology and Research FSU-2022-020
6 · The paper itself

Abstract

Microbial biofilms are known to defend against the host's immune system and provide resistant to antimicrobial medications. Biofilms can form on various human organ systems spanning the gastrointestinal, respiratory, cardiovascular, and urinary organ systems. Conditions caused by the yeast Candida albicans can range from irritating thrush, to systemic and life-threatening candidiasis. Initial contact between organism and surface is mediated electrically, with subsequent interactions developed biochemically. Since different cells have different electrical characteristics, we hypothesised that alteration in these properties may align with different strains' propensity for biofilm formation. We used three strains of C. albicans with different tendencies for biofilm formation and filament phenotype (the most filamentous strain nrg1 Δ/Δ, the least filamentous ume6 Δ/Δ, and wildtype DK318), we investigated the passive electrical properties, membrane potential V

Indexed as

BiofilmsCandida albicansMembrane PotentialsHumansAdhesionBioelectricityElectrophysiologyMembrane potentialZeta potential

Identifiers

PMID40593004
PMCPMC12219743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.